HomeCompareFRCEF vs CL

FRCEF vs CL: Dividend Comparison 2026

FRCEF yields 106.95% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FRCEF wins by $3.5K in total portfolio value
10 years
FRCEF
FRCEF
● Live price
106.95%
Share price
$1.87
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.3K
Annual income
$23.52
Full FRCEF calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — FRCEF vs CL

📍 FRCEF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFRCEFCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FRCEF + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FRCEF pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FRCEF
Annual income on $10K today (after 15% tax)
$9,090.91/yr
After 10yr DRIP, annual income (after tax)
$19.99/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, CL beats the other by $4,571.67/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FRCEF + CL for your $10,000?

FRCEF: 50%CL: 50%
100% CL50/50100% FRCEF
Portfolio after 10yr
$42.6K
Annual income
$2,712.74/yr
Blended yield
6.37%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

FRCEF
Analyst Ratings
1
Buy
Consensus: Buy
Price Target
$2.85
+52.4% upside vs current
Range: $2.85 — $2.85
Altman Z
2.4
Piotroski
3/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FRCEF buys
0
CL buys
0
No recent congressional trades found for FRCEF or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFRCEFCL
Forward yield106.95%2.43%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%28.6%
Portfolio after 10y$44.3K$40.8K
Annual income after 10y$23.52$5,401.96
Total dividends collected$14.6K$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold
Analyst price target$2.85$92.45

Year-by-year: FRCEF vs CL ($10,000, DRIP)

YearFRCEF PortfolioFRCEF Income/yrCL PortfolioCL Income/yrGap
1← crossover$16,048$5,347.59$11,012$312.01+$5.0KFRCEF
2$21,181$4,010.09$12,196$412.95+$9.0KFRCEF
3$25,137$2,473.31$13,599$549.66+$11.5KFRCEF
4$28,268$1,371.61$15,288$736.64+$13.0KFRCEF
5$30,968$720.78$17,353$995.28+$13.6KFRCEF
6$33,504$368.98$19,926$1,357.80+$13.6KFRCEF
7$36,036$186.54$23,194$1,873.82+$12.8KFRCEF
8$38,653$93.76$27,439$2,621.52+$11.2KFRCEF
9$41,405$46.99$33,088$3,727.38+$8.3KFRCEF
10$44,327$23.52$40,806$5,401.96+$3.5KFRCEF

FRCEF vs CL: Complete Analysis 2026

FRCEFStock

Fletcher Building Limited, together with its subsidiaries, manufactures and distributes building products in New Zealand, Australia, and internationally. It operates through Building Products, Distribution, Concrete, Residential and Development, Construction, and Australia segments. The Building Products segment manufactures, markets, and distributes building products used to build homes; and buildings and infrastructure, including insulations, plasterboards, laminate surfaces, and plastic and concrete piping for the commercial and residential markets. The Distribution segment distributes building, plumbing, and pipeline products under the PlaceMakers, Mico, and Forman Building Systems brands. The Concrete segment engages in the extraction of aggregates, and production of cement and concrete. The Residential and Development segment builds residential homes and apartments; and develops and sells residential and commercial land. The Construction segment builds and maintains public and commercial buildings, transport and utilities infrastructure, and buildings and infrastructure, as well as designs, constructs, and maintains roads and civil infrastructure. The Australia segment manufactures and distributes building materials, such as insulation, plasterboard, laminate surfaces, steel roofing, and plastic and concrete piping for a range of industries across Australia. The company was founded in 1909 and is headquartered in Auckland, New Zealand.

Full FRCEF Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this FRCEF vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FRCEF vs SCHDFRCEF vs JEPIFRCEF vs OFRCEF vs KOFRCEF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.